19-50510383-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The ENST00000598418.6(JOSD2):c.49G>A(p.Glu17Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000062 in 1,613,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E17Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000598418.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JOSD2 | NM_001270639.2 | c.49G>A | p.Glu17Lys | missense_variant | 2/5 | ENST00000598418.6 | NP_001257568.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JOSD2 | ENST00000598418.6 | c.49G>A | p.Glu17Lys | missense_variant | 2/5 | 1 | NM_001270639.2 | ENSP00000468956 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248686Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134818
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1461076Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726832
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2022 | The c.49G>A (p.E17K) alteration is located in exon 2 (coding exon 1) of the JOSD2 gene. This alteration results from a G to A substitution at nucleotide position 49, causing the glutamic acid (E) at amino acid position 17 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at